awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35012335-34926AB7-3699-4328-9414-50DD5D72C98E
Q35012335-34926AB7-3699-4328-9414-50DD5D72C98E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35012335-34926AB7-3699-4328-9414-50DD5D72C98E
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
P2860
Q35012335-34926AB7-3699-4328-9414-50DD5D72C98E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35012335-34926AB7-3699-4328-9414-50DD5D72C98E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
676d3b54a8aa610d342e37560b8a8f3164b72e56
P2860
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.